RCAMU
JAZZ icon

Rothschild & Co Asset Management US’s Jazz Pharmaceuticals JAZZ Stock Holding History

Rothschild & Co Asset Management US’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$8.32M Sell
52,249
-6,568
-11% -$963K 0.13% 123
2022
Q3 		$7.84M Sell
58,817
-8,645
-13% -$1.31M 0.13% 128
2022
Q2 		$10.5M Sell
67,462
-4,143
-6% -$638K 0.16% 111
2022
Q1 		$11.1M Sell
71,605
-38,619
-35% -$5.6M 0.14% 126
2021
Q4 		$14M Sell
110,224
-1,008
-0.9% -$132K 0.16% 138
2021
Q3 		$14.5M Sell
111,232
-7,293
-6% -$1.1M 0.18% 143
2021
Q2 		$21.1M Buy
118,525
+4,667
+4% +$808K 0.25% 126
2021
Q1 		$18.7M Sell
113,858
-7,093
-6% -$1.17M 0.23% 130
2020
Q4 		$20M Sell
120,951
-24,265
-17% -$3.61M 0.26% 135
2020
Q3 		$20.7M Sell
145,216
-28,273
-16% -$3.51M 0.37% 118
2020
Q2 		$19.1M Sell
173,489
-25,208
-13% -$2.79M 0.28% 152
2020
Q1 		$19.8M Sell
198,697
-16,457
-8% -$2.13M 0.31% 126
2019
Q4 		$32.1M Sell
215,154
-9,072
-4% -$1.23M 0.33% 123
2019
Q3 		$28.7M Sell
224,226
-4,317
-2% -$579K 0.31% 136
2019
Q2 		$32.6M Buy
228,543
+98,491
+76% +$13.2M 0.35% 117
2019
Q1 		$18.6M Buy
130,052
+5,434
+4% +$709K 0.2% 194
2018
Q4 		$15.4M Buy
+124,618
New +$18.5M 0.19% 200

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Rothschild & Co Asset Management US's JAZZ Position: Q4 2022 in Review

Rothschild & Co Asset Management US reduced its Jazz Pharmaceuticals (JAZZ) stake by 11% in Q4 2022, selling an estimated $963K and leaving 52,249 shares worth $8.32M. The position accounts for 0.13% of the portfolio, ranked #123.

Rothschild & Co Asset Management US first reported a position in JAZZ in Q4 2018 and has held it in 17 quarters since. The position peaked at $32.6M in Q2 2019. 486 funds tracked by Wall St. Rank hold JAZZ as of Q4 2022.

  • Rothschild & Co Asset Management US held 52,249 shares of Jazz Pharmaceuticals worth $8.32M as of Q4 2022.
  • Rothschild & Co Asset Management US sold 6,568 Jazz Pharmaceuticals shares in Q4 2022, an estimated $963K.
  • Jazz Pharmaceuticals made up 0.13% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #123 holding.
  • Rothschild & Co Asset Management US first reported a position in Jazz Pharmaceuticals in Q4 2018 and has held it in 17 quarters since.
  • Rothschild & Co Asset Management US's Jazz Pharmaceuticals position peaked at $32.6M in Q2 2019.
  • 486 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.